INNV-15. ANALYSIS OF CHALLENGES TO ACCRUAL IN CLINICAL TRIALS FOR NEWLY DIAGNOSED GLIOBLASTOMA

BACKGROUND: Glioblastoma (GBM) is the most common glioma, with an incidence of 3.2 per 100,000 adults, and approximately 12,500 new diagnoses each year in the US. With limited treatment options, there is a constant push to improve patient outcome by testing experimental therapies in clinical trials....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Metrus, Nicholas, Daher, Ahmad, Harrison, Rebecca, Majd, Nazanin, Maraka, Stefania, Nam, Joo Yeon, Trevino, Christopher, Weathers, Shiao-Pei, O’Brien, Barbara, Kamiya-Matsuoka, Carlos, Loghin, Monica, Alfaro, Kristin, Hunter, Kathy, Yung, W K Alfred, de Groot, John, Penas-Prado, Marta
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216910/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.588
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados